226 related articles for article (PubMed ID: 22740401)
1. Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81.
Rajesh S; Sridhar P; Tews BA; Fénéant L; Cocquerel L; Ward DG; Berditchevski F; Overduin M
J Virol; 2012 Sep; 86(18):9606-16. PubMed ID: 22740401
[TBL] [Abstract][Full Text] [Related]
2. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into hepatitis C virus receptor binding and entry.
Kumar A; Hossain RA; Yost SA; Bu W; Wang Y; Dearborn AD; Grakoui A; Cohen JI; Marcotrigiano J
Nature; 2021 Oct; 598(7881):521-525. PubMed ID: 34526719
[TBL] [Abstract][Full Text] [Related]
4. Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81.
Tian ZF; Shen H; Fu XH; Chen YC; Blum HE; Baumert TF; Zhao XP
World J Gastroenterol; 2009 Jan; 15(2):240-4. PubMed ID: 19132776
[TBL] [Abstract][Full Text] [Related]
5. Identification of ligands that target the HCV-E2 binding site on CD81.
Olaby RA; Azzazy HM; Harris R; Chromy B; Vielmetter J; Balhorn R
J Comput Aided Mol Des; 2013 Apr; 27(4):337-46. PubMed ID: 23612915
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus induces CD81 and claudin-1 endocytosis.
Farquhar MJ; Hu K; Harris HJ; Davis C; Brimacombe CL; Fletcher SJ; Baumert TF; Rappoport JZ; Balfe P; McKeating JA
J Virol; 2012 Apr; 86(8):4305-16. PubMed ID: 22318146
[TBL] [Abstract][Full Text] [Related]
7. Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.
Lavie M; Sarrazin S; Montserret R; Descamps V; Baumert TF; Duverlie G; Séron K; Penin F; Dubuisson J
J Virol; 2014 Sep; 88(18):10584-97. PubMed ID: 24990994
[TBL] [Abstract][Full Text] [Related]
8. Single-nucleotide variants in human CD81 influence hepatitis C virus infection of hepatoma cells.
Alberione MP; Moeller R; Kirui J; Ginkel C; Doepke M; Ströh LJ; Machtens JP; Pietschmann T; Gerold G
Med Microbiol Immunol; 2020 Aug; 209(4):499-514. PubMed ID: 32322956
[TBL] [Abstract][Full Text] [Related]
9. A view of the E2-CD81 interface at the binding site of a neutralizing antibody against hepatitis C virus.
Harman C; Zhong L; Ma L; Liu P; Deng L; Zhao Z; Yan H; Struble E; Virata-Theimer ML; Zhang P
J Virol; 2015 Jan; 89(1):492-501. PubMed ID: 25339761
[TBL] [Abstract][Full Text] [Related]
10. The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor.
Masciopinto F; Campagnoli S; Abrignani S; Uematsu Y; Pileri P
Virus Res; 2001 Nov; 80(1-2):1-10. PubMed ID: 11597743
[TBL] [Abstract][Full Text] [Related]
11. Mathematical model of viral kinetics in vitro estimates the number of E2-CD81 complexes necessary for hepatitis C virus entry.
Padmanabhan P; Dixit NM
PLoS Comput Biol; 2011 Dec; 7(12):e1002307. PubMed ID: 22174670
[TBL] [Abstract][Full Text] [Related]
12. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
[TBL] [Abstract][Full Text] [Related]
13. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
[TBL] [Abstract][Full Text] [Related]
14. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
Meola A; Sbardellati A; Bruni Ercole B; Cerretani M; Pezzanera M; Ceccacci A; Vitelli A; Levy S; Nicosia A; Traboni C; McKeating J; Scarselli E
J Virol; 2000 Jul; 74(13):5933-8. PubMed ID: 10846074
[TBL] [Abstract][Full Text] [Related]
15. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
[TBL] [Abstract][Full Text] [Related]
16. The CD9, CD81, and CD151 EC2 domains bind to the classical RGD-binding site of integrin αvβ3.
Yu J; Lee CY; Changou CA; Cedano-Prieto DM; Takada YK; Takada Y
Biochem J; 2017 Feb; 474(4):589-596. PubMed ID: 27993971
[TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibition of hepatitis C virus E2 binding to CD81.
VanCompernolle SE; Wiznycia AV; Rush JR; Dhanasekaran M; Baures PW; Todd SC
Virology; 2003 Sep; 314(1):371-80. PubMed ID: 14517089
[TBL] [Abstract][Full Text] [Related]
18. Structure-function analysis of hepatitis C virus envelope-CD81 binding.
Petracca R; Falugi F; Galli G; Norais N; Rosa D; Campagnoli S; Burgio V; Di Stasio E; Giardina B; Houghton M; Abrignani S; Grandi G
J Virol; 2000 May; 74(10):4824-30. PubMed ID: 10775621
[TBL] [Abstract][Full Text] [Related]
19. Natural flavonoids effectively block the CD81 receptor of hepatocytes and inhibit HCV infection: a computational drug development approach.
Dey D; Biswas P; Paul P; Mahmud S; Ema TI; Khan AA; Ahmed SZ; Hasan MM; Saikat ASM; Fatema B; Bibi S; Rahman MA; Kim B
Mol Divers; 2023 Jun; 27(3):1309-1322. PubMed ID: 35821161
[TBL] [Abstract][Full Text] [Related]
20. Differential interaction strategies of hepatitis c virus genotypes during entry - An in silico investigation of envelope glycoprotein E2 - CD81 interaction.
Bhattacharjee C; Nandy SK; Das P; Mukhopadhyay A
Infect Genet Evol; 2019 Apr; 69():48-60. PubMed ID: 30639544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
